Narya Bio

Narya BioNarya Bio
Narya Bio

Narya Bio

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

2022Active8רחובות, Israel
Rate

About

Narya Bio is a biotechnology company focused on developing next-generation therapeutic antibodies. They leverage advanced computational and biological approaches to design antibodies with improved efficacy and safety profiles for diseases that are currently difficult to treat.

Technology stack

detected 2026-07-14
CDN
Email
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Narya Bio do?

Narya Bio is a biotechnology company focused on developing next-generation therapeutic antibodies. They leverage advanced computational and biological approaches to design antibodies with improved efficacy and safety profiles for diseases that are currently difficult to treat.

Where is Narya Bio headquartered?

Narya Bio is headquartered in רחובות, Israel.

When was Narya Bio founded?

Narya Bio was founded in 2022.

What industry does Narya Bio operate in?

Narya Bio operates in Biotech, Drug Discovery, Antibody Therapeutics, Genomics, AI-Driven Protein Design.

How many employees does Narya Bio have?

Narya Bio has approximately 8 people on record.

What is Narya Bio's revenue?

StartupHub estimates Narya Bio's annual revenue at $868K (range $470K to $3.5M, 64% confidence), based on comparable companies in the sector.